Cerflux Patents – Insights & Stats (Updated 2023)

Cerflux has a total of 8 patents globally, out of which 2 have been granted. Of these 8 patents, more than 87% patents are active. The United States of America is where Cerflux has filed the maximum number of patents. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Cerflux.

Cerflux was founded in 2018. Cerflux provides personalized medical technology for matching medicines to tumours, with the goal of improving results and quality of life while lowering cancer treatment time, suffering, and expense.

Do read about some of the most popular patents of Cerflux which have been covered by us in this article and also you can find Cerflux patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Cerflux patent portfolio.

How many patents do the Founder and CEO of Cerflux have?

The Founder Karim Budhwani have 0 patents and CEO Dr. Karim I. Budhwani have 8 patents.

How many patents does Cerflux have?

Cerflux has a total of 8 patents globally. These patents belong to 2 unique patent families. Out of 8 patents, 7 patents are active.

How Many Patents did Cerflux File Every Year?

Cerflux Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantCerflux Applications FiledCerflux Patents Granted
20231
202121
20196

How many Cerflux patents are Alive/Dead?

Worldwide Patents

Cerflux Patent Portfolio

How Many Patents did Cerflux File in Different Countries?

Cerflux Worldwide Patent Filing

Countries in which Cerflux Filed Patents

CountryPatent
United States Of America2
United Kingdom2
Canada1
Europe1
India1

Where are Research Centers of Cerflux Patents Located?

The Research Centers of Cerflux Patents is the United States of America.

What Percentage of Cerflux US Patent Applications Were Granted?

Cerflux (Excluding its subsidiaries) has filed 2 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 1 have been granted leading to a grant rate of 100%.

Below are the key stats of Cerflux patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Cerflux?

Law FirmTotal ApplicationsSuccess Rate
Maynard Cooper & Gale Pc Birmingham2100%

List of Cerflux patents

Cerflux PatentsTitle
US11097274B2Biomimetic Array Device And Methods Of Using Same
US20210346890A1Biomimetic Array Device And Methods Of Using Same
EP3897985A4Biomimetic Array Device And Methods Of Using Same
CA3124645A1Biomimetic Array Device And Methods Of Using Same
GB2594871BBiomimetic Array Device And Methods Of Using Same
GB2615014ABiomimetic Array Device And Methods Of Using Same
IN202117032540ABiomimetic Array Device And Methods Of Using Same
WO2020132516A1Biomimetic Array Device And Methods Of Using Same

What are Cerflux key innovation segments?

What Technologies are Covered by Cerflux?

The chart below distributes patents filed by Cerflux in different countries on the basis of the technology protected in patents. It also represents the markets where Cerflux thinks it’s important to protect particular technology inventions.

R&D Focus: How has Cerflux search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Cerflux?

Related Articles

VoxelSensors Patents – Insights & Stats (Updated 2024)

VoxelSensors has a total of 36 patents globally, out of which 8 have been granted. Of these 36 patents, more than 94% patents are active. Europe (EPO) is where VoxelSensors has filed the maximum number of patents, followed by China and Israel. Parallelly, Belgium seems to be the main focused

Read More »

Alphapharm Patents – Insights & Stats (Updated 2024)

Alphapharm has a total of 108 patents globally, out of which 43 have been granted. Of these 108 patents, more than 18% patents are active. Australia is where Alphapharm has filed the maximum number of patents, followed by Europe (EPO) and United States of America. Parallelly, Australia seems to be

Read More »

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.